BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 27746161)

  • 21. MicroRNA-296-5p (miR-296-5p) functions as a tumor suppressor in prostate cancer by directly targeting Pin1.
    Lee KH; Lin FC; Hsu TI; Lin JT; Guo JH; Tsai CH; Lee YC; Lee YC; Chen CL; Hsiao M; Lu PJ
    Biochim Biophys Acta; 2014 Sep; 1843(9):2055-66. PubMed ID: 24915000
    [TBL] [Abstract][Full Text] [Related]  

  • 22. miR-134 inhibits non-small cell lung cancer growth by targeting the epidermal growth factor receptor.
    Qin Q; Wei F; Zhang J; Wang X; Li B
    J Cell Mol Med; 2016 Oct; 20(10):1974-83. PubMed ID: 27241841
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of epidermal growth factor receptor and its inhibitory microRNA141 as novel targets of Krüppel-like factor 8 in breast cancer.
    Li T; Lu H; Mukherjee D; Lahiri SK; Shen C; Yu L; Zhao J
    Oncotarget; 2015 Aug; 6(25):21428-42. PubMed ID: 26025929
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNA-133b inhibits the growth of non-small-cell lung cancer by targeting the epidermal growth factor receptor.
    Liu L; Shao X; Gao W; Zhang Z; Liu P; Wang R; Huang P; Yin Y; Shu Y
    FEBS J; 2012 Oct; 279(20):3800-12. PubMed ID: 22883469
    [TBL] [Abstract][Full Text] [Related]  

  • 25. H19 non coding RNA-derived miR-675 enhances tumorigenesis and metastasis of breast cancer cells by downregulating c-Cbl and Cbl-b.
    Vennin C; Spruyt N; Dahmani F; Julien S; Bertucci F; Finetti P; Chassat T; Bourette RP; Le Bourhis X; Adriaenssens E
    Oncotarget; 2015 Oct; 6(30):29209-23. PubMed ID: 26353930
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The miR-200 family regulates the epithelial-mesenchymal transition induced by EGF/EGFR in anaplastic thyroid cancer cells.
    Zhang Z; Liu ZB; Ren WM; Ye XG; Zhang YY
    Int J Mol Med; 2012 Oct; 30(4):856-62. PubMed ID: 22797360
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulatory Role of mir-203 in Prostate Cancer Progression and Metastasis.
    Saini S; Majid S; Yamamura S; Tabatabai L; Suh SO; Shahryari V; Chen Y; Deng G; Tanaka Y; Dahiya R
    Clin Cancer Res; 2011 Aug; 17(16):5287-98. PubMed ID: 21159887
    [TBL] [Abstract][Full Text] [Related]  

  • 28. miR-195 Inhibits Tumor Progression by Targeting RPS6KB1 in Human Prostate Cancer.
    Cai C; Chen QB; Han ZD; Zhang YQ; He HC; Chen JH; Chen YR; Yang SB; Wu YD; Zeng YR; Qin GQ; Liang YX; Dai QS; Jiang FN; Wu SL; Zeng GH; Zhong WD; Wu CL
    Clin Cancer Res; 2015 Nov; 21(21):4922-34. PubMed ID: 26080838
    [TBL] [Abstract][Full Text] [Related]  

  • 29. microRNA-137 is downregulated in thyroid cancer and inhibits proliferation and invasion by targeting EGFR.
    Luo Y; Li X; Dong J; Sun W
    Tumour Biol; 2016 Jun; 37(6):7749-55. PubMed ID: 26695142
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MiR-203 down-regulates Rap1A and suppresses cell proliferation, adhesion and invasion in prostate cancer.
    Xiang J; Bian C; Wang H; Huang S; Wu D
    J Exp Clin Cancer Res; 2015 Jan; 34(1):8. PubMed ID: 25636908
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA-564 is downregulated in glioblastoma and inhibited proliferation and invasion of glioblastoma cells by targeting TGF-β1.
    Jiang C; Shen F; Du J; Hu Z; Li X; Su J; Wang X; Huang X
    Oncotarget; 2016 Aug; 7(35):56200-56208. PubMed ID: 27621042
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Downregulation of miR-141-3p promotes bone metastasis via activating NF-κB signaling in prostate cancer.
    Huang S; Wa Q; Pan J; Peng X; Ren D; Huang Y; Chen X; Tang Y
    J Exp Clin Cancer Res; 2017 Dec; 36(1):173. PubMed ID: 29202848
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MiR-182 promotes prostate cancer progression through activating Wnt/β-catenin signal pathway.
    Wang D; Lu G; Shao Y; Xu D
    Biomed Pharmacother; 2018 Mar; 99():334-339. PubMed ID: 29353209
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MiR-181a promotes epithelial to mesenchymal transition of prostate cancer cells by targeting TGIF2.
    Zhiping C; Shijun T; Linhui W; Yapei W; Lianxi Q; Qiang D
    Eur Rev Med Pharmacol Sci; 2017 Nov; 21(21):4835-4843. PubMed ID: 29164579
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA-1908-5p contributes to the oncogenic function of the splicing factor SRSF3.
    Kim HR; Shin CH; Lee H; Choi KH; Nam DH; Ohn T; Kim HH
    Oncotarget; 2017 Jan; 8(5):8342-8355. PubMed ID: 28039456
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA-340 inhibits prostate cancer cell proliferation and metastasis by targeting the MDM2-p53 pathway.
    Huang K; Tang Y; He L; Dai Y
    Oncol Rep; 2016 Feb; 35(2):887-95. PubMed ID: 26718483
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Histone deacetylases activate hepatocyte growth factor signaling by repressing microRNA-449 in hepatocellular carcinoma cells.
    Buurman R; Gürlevik E; Schäffer V; Eilers M; Sandbothe M; Kreipe H; Wilkens L; Schlegelberger B; Kühnel F; Skawran B
    Gastroenterology; 2012 Sep; 143(3):811-820.e15. PubMed ID: 22641068
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Involvement of aberrantly activated HOTAIR/EZH2/miR-193a feedback loop in progression of prostate cancer.
    Ling Z; Wang X; Tao T; Zhang L; Guan H; You Z; Lu K; Zhang G; Chen S; Wu J; Qian J; Liu H; Xu B; Chen M
    J Exp Clin Cancer Res; 2017 Nov; 36(1):159. PubMed ID: 29141691
    [TBL] [Abstract][Full Text] [Related]  

  • 39. miR-205 Exerts tumor-suppressive functions in human prostate through down-regulation of protein kinase Cepsilon.
    Gandellini P; Folini M; Longoni N; Pennati M; Binda M; Colecchia M; Salvioni R; Supino R; Moretti R; Limonta P; Valdagni R; Daidone MG; Zaffaroni N
    Cancer Res; 2009 Mar; 69(6):2287-95. PubMed ID: 19244118
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA-590-3p promotes cell proliferation and invasion by targeting inositol polyphosphate 4-phosphatase type II in human prostate cancer cells.
    Chen H; Luo Q; Li H
    Tumour Biol; 2017 Mar; 39(3):1010428317695941. PubMed ID: 28345464
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.